Log In
BCIQ
Print this Print this
 

LP7-Lanthionine-apelin/APJ agonist

  Manage Alerts
Collapse Summary General Information
Company MorphoSys AG
DescriptionLantipeptide
Molecular Target Apelin receptor (APLNR) (APJ)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentDiscovery
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$22.3M

$22.3M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/07/2015

$22.3M

$22.3M

0

Get a free BioCentury trial today